Holen Sie sich die Stockscreener-App
16.65
2.75%
-0.47
Handel nachbörslich:
16.65
Schlusskurs vom Vortag:
$17.12
Offen:
$17.15
24-Stunden-Volumen:
934.03K
Relative Volume:
0.92
Marktkapitalisierung:
$1.30B
Einnahmen:
$1.64B
Nettoeinkommen (Verlust:
$-495.80M
KGV:
-2.5999
EPS:
-6.404
Netto-Cashflow:
$-45.25M
1W Leistung:
-15.87%
1M Leistung:
-7.29%
6M Leistung:
+49.46%
1J Leistung:
+26.71%
1-Tages-Spanne:
$16.24
$17.59
1-Wochen-Bereich:
$16.04
$20.49
52-Wochen-Spanne:
$8.70
$20.49
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
Firmenname
Integra Lifesciences Holdings Corp
Sektor
Branche
Telefon
(609) 275-0500
Adresse
1100 CAMPUS ROAD, PRINCETON, NJ
Compare IART vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
16.65 | 1.52B | 1.64B | -495.80M | -45.25M | -6.404 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-15 | Herabstufung | Argus | Buy → Hold |
| 2025-03-31 | Hochstufung | Argus | Hold → Buy |
| 2024-12-02 | Eingeleitet | Morgan Stanley | Underweight |
| 2024-10-07 | Hochstufung | BTIG Research | Sell → Neutral |
| 2024-07-30 | Herabstufung | BTIG Research | Neutral → Sell |
| 2024-07-30 | Herabstufung | Citigroup | Neutral → Sell |
| 2024-05-07 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-05-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-04-03 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-12-05 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-11-14 | Eingeleitet | CL King | Buy |
| 2023-08-24 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-07-12 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-08 | Herabstufung | Argus | Buy → Hold |
| 2023-05-24 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-05-23 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-07-25 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-04-13 | Herabstufung | Truist | Buy → Hold |
| 2021-12-17 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2021-09-15 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-05-27 | Eingeleitet | Citigroup | Neutral |
| 2020-04-03 | Eingeleitet | SunTrust | Buy |
| 2020-01-07 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2019-01-03 | Eingeleitet | SunTrust | Buy |
| 2018-11-28 | Eingeleitet | UBS | Neutral |
| 2018-08-07 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-07-26 | Hochstufung | BTIG Research | Neutral → Buy |
| 2018-07-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2018-01-02 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-11-09 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-10-30 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2017-10-27 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-06-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-05-02 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-01-13 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-01-06 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-12-12 | Eingeleitet | UBS | Buy |
Alle ansehen
Integra Lifesciences Holdings Corp Aktie (IART) Neueste Nachrichten
Integra LifeSciences earnings up next: Can turnaround hold? - Investing.com
UBS initiates Integra LifeSciences stock with neutral rating - Investing.com
Ultrasonic Aspirator Market Size Projected to Reach USD 376.32 Million by 2035 | SNS Insider - GlobeNewswire Inc.
Integra LifeSciences (IART) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
Integra Lifesciences Holdings Corp (IART) Institutional Confidence - TradingKey
Integra Lifesciences Holdings Corp (IART) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Integra Lifesciences Holdings Corp (IART) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Integra Lifesciences Holdings Corp - TradingKey
IART|Integra Lifesciences Holdings Corp|Price:19.530|Chg%:-0.260 - TradingKey
Integra Lifesciences Holdings Corp (IART) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
TradingKey - TradingKey
Integra Lifesciences Holdings Corp (IART) Cash Flow - TradingKey
Integra LifeSciences Holdings Corporation (IART) Stock Price, News, Quote & History - Yahoo! Finance Canada
Integra Lifesciences Holdings Corp (IART) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Kaskela Law Firm Announces Investigation of Integra LifeSciences - GuruFocus
IART|Integra Lifesciences Holdings Corp|Price:19.790|Chg%:+1.230 - TradingKey
How Integra LifeSciences’ Earnings Outperformance Track Record At Integra LifeSciences Holdings (IART) Has Changed Its Investment Story - Yahoo Finance
A Look at Integra Lifesciences Holdings Corp (IART) After 3.1% D - GuruFocus
Integra LifeSciences Holdings (IART) Stock Still Looks Below Fair Value Following A 70% Five Year Fall - Yahoo Finance
Integra LifeSciences to announce Q2 2026 results on July 29 - scanx.trade
Integra LifeSciences Holdings Corporation (IART) Soars to 52-Week High, Time to Cash Out? - Yahoo Finance
Integra LifeSciences to Release Results Before Market Open July 29 - Stock Titan
Integra LifeSciences stock hits 52-week high at 18.93 USD - Investing.com
ETFs Investing in Integra LifeSciences Holdings Corporation Stocks - TradingView
IART Initiated Coverage by BMO Capital -- Rating Set to Market P - GuruFocus
BMO initiates Integra LifeSciences stock at Market Perform By Investing.com - Investing.com India
BMO initiates Integra LifeSciences stock at Market Perform - Investing.com
Why Integra LifeSciences (IART) Stock Is Up Today - Yahoo Finance
Integra LifeSciences (IART) Coverage Initiated with Market Perfo - GuruFocus
Form 4 Integra LifeSciences Holdings For: 6 July By Investing.com - Investing.com Canada
Integra Lifesciences (NASDAQ: IART) SVP uses 937 shares for tax withholding - Stock Titan
Integra LifeSciences (IART) grants EVP 5,590 RSUs vesting over 3 years - Stock Titan
Integra LifeSciences (IART) EVP awarded 11,180 RSUs in new equity grant - Stock Titan
IART CFO Lea Daniels Knight uses 5,226 shares to satisfy tax obligations - Stock Titan
Integra Lifesciences Holdings Corp (IART) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Integra LifeSciences Appoints Topaz Kirlew Chief Regulatory Officer - Finviz
Integra LifeSciences Names Topaz Kirlew Chief Regulatory Officer - citybiz
Integra LifeSciences taps interim regulatory chief for global role - Stock Titan
Integra Lifesciences Holdings Corp (IART) Shares Fall 4.2% -- Wh - GuruFocus
Is Integra LifeSciences’ New Commercial Structure Recasting Its Execution Story for Investors in IART? - Yahoo Finance
Integra LifeSciences Hits New 52-Week High at $18.49 - MarketsMojo
Integra LifeSciences Holdings stock hits 52-week high at $18.30 - Investing.com
Zacks.com featured highlights TPG Mortgage Investment Trust, Silvercorp and Integra LifeSciences - Yahoo Finance
Surgical Equipment & ConsumablesSpecialty Stocks Q1 Results: Benchmarking Integra LifeSciences (NASDAQ:IART) - Yahoo Finance
Integra Lifesciences Holdings Corporation Announces Executive Changes - marketscreener.com
Integra LifeSciences Announces Key Executive Appointments - The Manila Times
Integra LifeSciences reshuffles commercial leadership in medtech push - Stock Titan
Integra LifeSciences: New Beginning (NASDAQ:IART) - Seeking Alpha
Integra LifeSciences StockSunday background on risks and outlook - AD HOC NEWS
Integra LifeSciences Opens with 5.47% Gain, Marking Significant Gap Up - MarketsMojo
symbol__ Stock Quote Price and Forecast - CNN
Finanzdaten der Integra Lifesciences Holdings Corp-Aktie (IART)
Umsatz
Nettogewinn
Free Cashflow
ENV
Integra Lifesciences Holdings Corp-Aktie (IART) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Mar 10 '26 |
Option Exercise |
0.00 |
1,216 |
0 |
23,152 |
| Poul Mojdeh | President & CEO |
Jan 06 '26 |
Option Exercise |
0.00 |
1,390 |
0 |
1,390 |
| GRAVES JEFFREY A | Director |
Nov 05 '25 |
Buy |
11.35 |
9,000 |
102,150 |
41,086 |
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Oct 12 '25 |
Option Exercise |
0.00 |
11,965 |
0 |
25,217 |
1.04%
11.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):